StonvexLoading…
StonvexStonvexStonvexCore line items from TCOM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.94B | $7.31B | $6.28B | $2.91B |
Operating Income | $2.26B | $1.94B | $1.59B | $15.00M |
Net Income | $4.76B | $2.34B | $1.40B | $206.00M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $38.24B | $33.23B | $30.86B | $27.79B |
Total Liabilities | $13.55B | $13.58B | $13.54B | $11.41B |
Cash & Equivalents | $5.70B | $6.64B | $5.86B | $2.46B |
Free Cash Flow OCF − CapEx | $1.95B | $2.61B | $3.01B | $308.00M |
Shares Outstanding | 649.58M | 653.27M | 644.09M | 646.07M |